Clinical Trial Update: Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial tested everolimus in combination with imatinib mesylate in adults with locally advanced, recurrent, or metastatic soft tissue sarcoma, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma
• Synovial Sarcoma

Drugs mentioned

• Afinitor (everolimus)
• Gleevec (Imatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Synovial Sarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-08